Factors related to discontinuous use of inhaled drugs in COPD patients: A population-based cohort study in Lazio (Italy) Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD Year: 2012
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020 Year: 2021
Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018 Year: 2019
The use of high-dose inhaled corticosteroids and add-on therapy in children in the UK: an observational study of 4332 patients Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma Year: 2004
Sub-optimal asthma control with medium- or high-dose ICS/LABA: a retrospective cohort study from Japan claims database Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019
Anti-inflammatory asthma therapy adherence in paediatric patients: The PACMAN cohort study Source: Annual Congress 2010 - Management of airway disease Year: 2010
Inhaled corticosteroid/long-acting beta-2 agonist (ICS/LABA) combination can decrease mortality of COPD patients, a nationwide population-based cohort study in Taiwan Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006
High-dose inhaled corticosteroids and add-on therapy use in adults in the UK: an observational study of 22,027 patients Source: Annual Congress 2004 - Primary care: asthma Year: 2004
Adequacy of treatment in COPD patients referred to the emergency room for disease exacerbation: an Italian multicentre observational study (the COXER study) Source: Annual Congress 2008 - Management of COPD Year: 2008
Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020
Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004
Osteoporosis onset in patients prescribed ICS for COPD: matched cohort study Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018
Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016 Source: Eur Respir J, 53 (4) 1802130; 10.1183/13993003.02130-2018 Year: 2019
Temporal change in pediatric asthma exacerbation rates - a nationwide Swedish asthma cohort (HERA) Source: Virtual Congress 2021 – Paediatric asthma and bronchopulmonary dysplasia Year: 2021
MARTE: an observational study on clinical and sociodemographic characteristics of asthmatic patients receiving maintenance and rescue treatment in Spain Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018
Non-adherence and sub-optimal treatment with asthma medications in young adults: a population-based cohort study Source: Virtual Congress 2021 – Asthma burden and management I Year: 2021
How far is real life from COPD therapy guidelines? An observational study on 4000 patients in Italy Source: Annual Congress 2010 - Management of airway disease Year: 2010
“Stepping down” in mild-to-moderate asthmatic children being well controlled while receiving low doses of inhaled corticosteroids (ICS): Daily vs. cyclical ICS administration (prospective, randomized, multicentre, open-label trial) Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013
Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with high-dose ICS/LABA therapy (on GINA step 5) prior to study entry: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021